This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Einhorn, Icahn and Loeb Circle Their Latest Victims

NEW YORK ( TheStreet) -- Prominent activist investors are making noise again. It might be worth following them in their latest investments.

Activist investors, who take stakes in companies and shake up management or change strategies to wring out investment gains, have been busy doing their homework on undervalued stocks. With keen eyes for companies with turnaround potential, Carl Icahn and Daniel Loeb have found the latest targets. On the other hand, David Einhorn knows when to take the other side of the bet on an overvalued stock and has made a short position in his latest victim.

This flurry of activity could be a sign for a new investment opportunities. Given the solid track records of these famous investors for getting the value that they want out of a company, it's worth taking a look at these stocks.
Carl Icahn

This Coffee Brewer's Days May Be Numbered

In mid-October, Greenlight Capital's Einhorn presented his latest short idea at an investor conference. The play was to short shares -- or to bet on a decline -- in Green Mountain Coffee Roasters (GMCR), which has more than doubled in the past year.

Einhorn is most famously known for his short position in Lehman Brothers prior to the collapse of the investment bank. In his presentation on Green Mountain, he brought into question the company's accounting practices, its relationship with key vendors and the imminent expiration of the K-cup patent, a product used in its single-serve coffee machines.

Green Mountain is scheduled to release fourth-quarter earnings after the market close today. The eloquent and locquacious hedge fund manager surely will be listening closely for answers to his concerns. Since Einhorn announced his short position, the stock has declined 24%.

WebMD -- Is This Patient Healthy?

Icahn recently increased his stake in online health-information provider WebMD (WBMD - Get Report) to 9.5% from an initial stake of 7.9% in October.

Icahn, known for pushing change at companies through management shakeups, strategy switches or outright sales of businesses, identified WebMD as an undervalued stock from a long-term perspective. His initial filing noted that he "may seek to have conversations from time to time with management."

A shareholder-rights plan was adopted by the company shortly after Icahn's initial investment was made, discouraging investors from acquiring more than 12% of the shares outstanding.
1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
GMCR $91.67 -0.30%
BRCD $9.61 0.00%
IRM $36.53 0.00%
YHOO $36.60 0.00%
WBMD $62.74 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs